The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 33 (3) , 468-482
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite statusOncoImmunology, 2019
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyThe Lancet, 2018
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite InstabilityImmunity, 2016
- The consensus molecular subtypes of colorectal cancerNature Medicine, 2015
- Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisJournal of Clinical Investigation, 2015
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory CheckpointsCancer Discovery, 2015
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic ValuePLOS Medicine, 2013
- Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrenceColorectal Disease, 2009
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Effector Memory T Cells, Early Metastasis, and Survival in Colorectal CancerNew England Journal of Medicine, 2005